The report highlights Genmab's commitment to becoming a sustainable and socially responsible biotechnology company. The company established a new CSR strategy, focusing on four pillars: Science-Driven Health Innovations for Patients; Employee Well-Being and Vitality; Ethics and Transparency; and Environmental and Community Sustainability. The report includes a detailed account of their progress in 2021, showcasing their commitment to diversity, equity and inclusion, as well as their efforts to reduce their environmental impact and support local communities. Genmab also highlights its commitment to transparency and ethical conduct, outlining its compliance program and Code of Conduct.
Issuing Company Genmab A/S
Report Type Sustainability Report
Report Language EN
Report Filesize 5.5 MB
No. of Pages 39 pages
Reporting periodJanuary 1-December 31, 2021
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs; others
Materiality Assessmenttrue
